The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVReviewLutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical ApplicationsSharmila Banerjee, M. R. A. Pillai*, and F. F. (Russ) KnappView Author Information Radiopharmaceuticals Chemistry Section, Bhabha Atomic Research Centre (BARC), Mumbai 400 085, India Molecular Group of Companies, Puthuvype, Ernakulam, Kerala 682 508, India Medical Radioisotope Program, Oak Ridge National Laboratory (ORNL), P.O. Box 2008, 1 Bethel Valley Road, Oak Ridge, Tennessee 37830-6229, United States*E-mail: [email protected]Cite this: Chem. Rev. 2015, 115, 8, 2934–2974Publication Date (Web):April 13, 2015Publication History Received27 March 2014Published online13 April 2015Published inissue 22 April 2015https://pubs.acs.org/doi/10.1021/cr500171ehttps://doi.org/10.1021/cr500171ereview-articleACS PublicationsCopyright © 2015 American Chemical SocietyRequest reuse permissionsArticle Views6918Altmetric-Citations197LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Cancer,Cancer therapy,Immunology,Nuclear medicine,Peptides and proteins Get e-Alerts
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
Parker, C., Nilsson, S., Heinrich, D., Helle, S. I., O'Sullivan, J. M., Fosså, S. D., Chodacki, A., Wiechno, P., Logue, J., Seke, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213755 · Cited by 3,408
Smith, R. M., & Martell, A. E. (1975) · Springer eBooks · doi:10.1007/978-1-4613-4452-0 · Cited by 2,264
Paul Ehrlich's magic bullet concept: 100 years of progress
Strebhardt, K., & Ullrich, A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2394 · Cited by 1,457
Kwekkeboom, D. J., de Herder, W. W., Kam, B. L., van Eijck, C. H., van Essen, M., Kooij, P. P., Feelders, R. A., van Aken, M. O., & Krenning, E. P. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2553 · Cited by 1,456
The Nubase evaluation of nuclear and decay properties
Audi, G., Bersillon, O., Blachot, J., & Wapstra, A. H. (2003) · Nuclear Physics A · doi:10.1016/j.nuclphysa.2003.11.001 · Cited by 1,338
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
Reubi, J. C. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0007 · Cited by 1,131
Reubi, J. C., Schär, J.-C., Waser, B., Wenger, S., Heppeler, A., Schmitt, J. S., & Mäcke, H. R. (2000) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050034 · Cited by 1,127
Function and interactions of integrins
van der Flier, A., & Sonnenberg, A. (2001) · Cell and Tissue Research · doi:10.1007/s004410100417 · Cited by 1,039
Anastasi, A., Erspamer, V., & Bucci, M. (1971) · Experientia · doi:10.1007/bf02145873 · Cited by 931
Lanthanide and Actinide Chemistry
Cotton, S. (2006) · Wiley eBooks · doi:10.1002/0470010088 · Cited by 901
Zaknun, J. J., Bodei, L., Mueller-Brand, J., Pavel, M. E., Baum, R. P., Hörsch, D., O’Dorisio, M. S., O’Dorisiol, T. M., Howe, J. R., Cremonesi, M., et al. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2330-6 · Cited by 818
Therapeutic Radiopharmaceuticals
Volkert, W. A., & Hoffman, T. J. (1999) · Chemical Reviews · doi:10.1021/cr9804386 · Cited by 724
Kwekkeboom, D. J., Teunissen, J. J., Bakker, W. H., Kooij, P. P., de Herder, W. W., Feelders, R. A., van Eijck, C. H., Esser, J.-P., Kam, B. L., & Krenning, E. P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.066 · Cited by 657
Imhof, A., Brunner, P., Marincek, N., Briel, M., Schindler, C., Rasch, H., Mäcke, H. R., Rochlitz, C., Müller-Brand, J., & Walter, M. A. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.7873 · Cited by 641
Pallaghy, P. K., Norton, R. S., Nielsen, K. J., & Craik, D. J. (1994) · Protein Science · doi:10.1002/pro.5560031022 · Cited by 523
Ginj, M., Zhang, H., Waser, B., Cescato, R., Wild, D., Wang, X., Erchegyi, J., Rivier, J., Mäcke, H. R., & Reubi, J. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607761103 · Cited by 515
Bander, N. H., Milowsky, M. I., Nanus, D. M., Kostakoglu, L., Vallabhajosula, S., & Goldsmith, S. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.160 · Cited by 509
[177Lu-DOTA0,Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients
Kwekkeboom, D. J., Bakker, W. H., Kooij, P. P., Konijnenberg, M. W., Srinivasan, A., Erion, J. L., Schmidt, M. A., Bugaj, J. L., de Jong, M., & Krenning, E. P. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100574 · Cited by 471
Kwekkeboom, D. J., Bakker, W. H., Kam, B. L., Teunissen, J. J. M., Kooij, P. P. M., de Herder, W. W., Feelders, R. A., van Eijck, C. H. J., de Jong, M., Srinivasan, A., et al. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1050-8 · Cited by 424
Radiometals for Combined Imaging and Therapy
Cutler, C. S., Hennkens, H. M., Sisay, N., Huclier-Markai, S., & Jurisson, S. S. (2013) · Chemical Reviews · doi:10.1021/cr3003104 · Cited by 395
Garofalo, C., Koda, M., Cascio, S., Sulkowska, M., Kanczuga-Koda, L., Golaszewska, J., Russo, A., Sulkowski, S., & Surmacz, E. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1913 · Cited by 370
Bifunctional Chelators for Therapeutic Lanthanide Radiopharmaceuticals
Liu, S., & Edwards, D. S. (2001) · Bioconjugate Chemistry · doi:10.1021/bc000070v · Cited by 351
Somatostatin receptor-targeted radionuclide therapy of tumors: Preclinical and clinical findings
de Jong, M., Valkema, R., Jamar, F., Kvols, L. K., Kwekkeboom, D. J., Breeman, W. A. P., Bakker, W. H., Smith, C., Pauwels, S., & Krenning, E. P. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2002.31027 · Cited by 346
Radiolabeled Peptides: Valuable Tools for the Detection and Treatment of Cancer
Fani, M., Maecke, H. R., & Okarvi, S. M. (2012) · Theranostics · doi:10.7150/thno.4024 · Cited by 333
Targeted therapy of cancer with radiolabeled antibodies.
Goldenberg, D. M. (2002) · PubMed · Cited by 318
Wild, D., Schmitt, J. S., Ginj, M., Mäcke, H. R., Bernard, B. F., Krenning, E., de Jong, M., Wenger, S., & Reubi, J.-C. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1255-5 · Cited by 310
Sessler, J. L., & Miller, R. A. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00314-7 · Cited by 278
Rosenblat, T. L., McDevitt, M. R., Mulford, D. A., Pandit-Taskar, N., Divgi, C. R., Panageas, K. S., Heaney, M. L., Chanel, S., Morgenstern, A., Sgouros, G., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0382 · Cited by 271
Chang, C. A., Francesconi, L. C., Malley, M. F., Kumar, K., Gougoutas, J. Z., Tweedle, M. F., Lee, D. W., & Wilson, L. J. (1993) · Inorganic Chemistry · doi:10.1021/ic00068a020 · Cited by 264
The Synthesis and Chelation Chemistry of DOTA−Peptide Conjugates
De León-Rodríguez, L. M., & Kovacs, Z. (2008) · Bioconjugate Chemistry · doi:10.1021/bc700328s · Cited by 262
Gd-DOTA: characterization of a new paramagnetic complex.
Bousquet, J. C., Saini, S., Stark, D. D., Hahn, P. F., Nigam, M., Wittenberg, J., & Ferrucci, J. T. (1988) · Radiology · doi:10.1148/radiology.166.3.3340763 · Cited by 257
Meyer, M., Dahaoui-Gindrey, V., Claude Lecomte, B., & Guilard, R. (1998) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(98)00169-6 · Cited by 253
Lutetium-labelled peptides for therapy of neuroendocrine tumours
Kam, B. L. R., Teunissen, J. J. M., Krenning, E. P., de Herder, W. W., Khan, S., van Vliet, E. I., & Kwekkeboom, D. J. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-2039-y · Cited by 246
Kunikowska, J., Królicki, L., Hubalewska-Dydejczyk, A., Mikołajczak, R., Sowa-Staszczak, A., & Pawlak, D. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1833-x · Cited by 238
Van Essen, M., Krenning, E. P., De Jong, M., Valkema, R., & Kwekkeboom, D. J. (2007) · Acta Oncologica · doi:10.1080/02841860701441848 · Cited by 221
Debinski, W., Obiri, N. I., Powers, S. K., Pastan, I. H., & Puri, R. K. (1995) · PubMed · Cited by 216
Radiopharmaceutical development of radiolabelled peptides
Fani, M., & Maecke, H. R. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-2001-z · Cited by 214
Prasanphanich, A. F., Nanda, P. K., Rold, T. L., Ma, L., Lewis, M. R., Garrison, J. C., Hoffman, T. J., Sieckman, G. L., Figueroa, S. D., & Smith, C. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705347104 · Cited by 213
18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis
Chen, X., Park, R., Shahinian, A. H., Tohme, M., Khankaldyyan, V., Bozorgzadeh, M. H., Bading, J. R., Moats, R., Laug, W. E., & Conti, P. S. (2004) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2003.10.002 · Cited by 212
[177Lu-DOTA0,Tyr3]octreotate for somatostatin receptor-targeted radionuclide therapy
de Jong, M., Breeman, W. A. P., Bernard, B. F., Bakker, W. H., Schaar, M., van Gameren, A., Bugaj, J. E., Erion, J. L., Schmidt, M. A., Srinivasan, A., et al. (2001) · International Journal of Cancer · Cited by 210
Skeletal localization of samarium-153 chelates: potential therapeutic bone agents.
Goeckeler, W. F., Edwards, B., Volkert, W. A., Holmes, R. A., Simon, J., & Wilson, D. (1987) · PubMed · Cited by 209
Structural Origin of the High Affinity of a Chemically Evolved Lanthanide‐Binding Peptide
Nitz, M., Sherawat, M., Franz, K. J., Peisach, E., Allen, K. N., & Imperiali, B. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200460028 · Cited by 208
In Vitro and in Vivo Imaging Studies of a New Endohedral Metallofullerene Nanoparticle
Fatouros, P. P., Corwin, F. D., Chen, Z.-J., Broaddus, W. C., Tatum, J. L., Kettenmann, B., Ge, Z., Gibson, H. W., Russ, J. L., Leonard, A. P., et al. (2006) · Radiology · doi:10.1148/radiol.2403051341 · Cited by 206
Perk, L. R., Visser, G. W. M., Vosjan, M. J. W. D., van Walsum, M., Tijink, B. M., Leemans, C. R., & van Dongen, G. A. M. S. (2005) · PubMed · Cited by 205
Zhang, H., Chen, J., Waldherr, C., Hinni, K., Waser, B., Reubi, J. C., & Maecke, H. R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3845 · Cited by 201
Radiopeptide Imaging and Therapy in Europe
Ambrosini, V., Fani, M., Fanti, S., Forrer, F., & Maecke, H. R. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.085753 · Cited by 201
Production logistics of 177Lu for radionuclide therapy
Pillai, M. R. A., Chakraborty, S., Das, T., Venkatesh, M., & Ramamoorthy, N. (2003) · Applied Radiation and Isotopes · doi:10.1016/s0969-8043(03)00158-1 · Cited by 191
Self-citationEzziddin, S., Attassi, M., Yong-Hing, C. J., Ahmadzadehfar, H., Willinek, W., Grünwald, F., Guhlke, S., Biersack, H.-J., & Sabet, A. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.125336 · Cited by 191
Intraperitoneal Radioimmunotherapy of Ovarian Cancer with177Lu-CC49: A Phase I/II Study
Alvarez, R. D., Partridge, E. E., Khazaeli, M. B., Plott, G., Austin, M., Kilgore, L. C., Russell, C. D., Liu, T., Grizzle, W. E., Schlom, J., et al. (1997) · Gynecologic Oncology · doi:10.1006/gyno.1996.4577 · Cited by 181
Esser, J. P., Krenning, E. P., Teunissen, J. J. M., Kooij, P. P. M., van Gameren, A. L. H., Bakker, W. H., & Kwekkeboom, D. J. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0172-9 · Cited by 179
Wehrmann, C., Senftleben, S., Zachert, C., Müller, D., & Baum, R. P. (2007) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2006.325 · Cited by 177
Viola-Villegas, N., & Doyle, R. P. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.03.013 · Cited by 167
Benetollo, F., Bombieri, G., Calabi, L., Aime, S., & Botta, M. (2002) · Inorganic Chemistry · doi:10.1021/ic025790n · Cited by 166
Loncin, M. F., Desreux, J. F., & Merciny, E. (1986) · Inorganic Chemistry · doi:10.1021/ic00235a031 · Cited by 157
Kneifel, S., Cordier, D., Good, S., Ionescu, M.-C. S., Ghaffari, A., Höfer, S., Kretzschmar, M., Tolnay, M., Apostolidis, C., Waser, B., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2820 · Cited by 153
Schlom, J. (1986) · PubMed · Cited by 148
Therapeutic radionuclides and nuclear data
Qaim, S. M. (2001) · Radiochimica Acta · doi:10.1524/ract.2001.89.4-5.297 · Cited by 146
Forrer, F., Uusijärvi, H., Storch, D., Maëcke, H. R., & Mueller‐Brand, J. (2005) · PubMed · Cited by 146
Wild, D., Frischknecht, M., Zhang, H., Morgenstern, A., Bruchertseifer, F., Boisclair, J., Provencher-Bolliger, A., Reubi, J., & Maëcke, H. R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1186 · Cited by 137
A process for the separation of 177Lu from neutron irradiated 176Yb targets
Horwitz, E. P., McAlister, D. R., Bond, A. H., Barrans, R. E., & Williamson, J. M. (2005) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2005.02.005 · Cited by 134
Peptides and Receptors in Image-Guided Therapy: Theranostics for Neuroendocrine Neoplasms
Baum, R. P., Kulkarni, H., & Carreras, C. (2012) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2012.01.002 · Cited by 134
Targeted Radionuclide Therapy - An Overview
Dash, A. K., Knapp, F. F., & Pillai, M. (2013) · Current Radiopharmaceuticals · doi:10.2174/18744710113066660023 · Cited by 133
Self-citationVallabhajosula, S., Goldsmith, S. J., Kostakoğlu, L., Milowsky, M. I., Nanus, D. M., & Bander, N. H. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1004-0023 · Cited by 130
Vallabhajosula, S., Kuji, I., Hamacher, K. A., Konishi, S., Kostakoğlu, L., Kothari, P. A., Milowsky, M. I., Nanus, D. M., Bander, N. H., & Goldsmith, S. J. (2005) · PubMed · Cited by 130
Zhang, H., Schuhmacher, J., Waser, B., Wild, D., Eisenhut, M., Reubi, J. C., & Maëcke, H. R. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0347-4 · Cited by 128
Targeting the Nucleus: An Overview of Auger-Electron Radionuclide Therapy
Cornelissen, B. T., & Vallis, K. A. (2010) · Current Drug Discovery Technologies · doi:10.2174/157016310793360657 · Cited by 124
Nonuniformity of tumor dose in radioimmunotherapy.
Humm, J. L., & Cobb, L. (1990) · PubMed · Cited by 122
Radioimmunotherapy with α-Particle Emitting Radioimmunoconjugates
Zalutsky, M. R., & Bigner, D. D. (1996) · Acta Oncologica · doi:10.3109/02841869609101654 · Cited by 121
Liepe, K., & Kotzerke, J. (2007) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e32825a6adc · Cited by 120
Radioiodine: The Classic Theranostic Agent
Silberstein, E. B. (2012) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2011.12.002 · Cited by 110
Molecular–Genetic Imaging: A Nuclear Medicine–Based Perspective
Blasberg, R. G., & Gelovani, J. G. (2002) · Molecular Imaging · doi:10.1162/15353500200202127 · Cited by 109
Woodburn, K. W., Fan, Q., Miles, D., Kessel, D. H., Luo, Y., & Young, S. W. (1997) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1997.tb08579.x · Cited by 109
Intraperitoneal radioimmunotherapy of ovarian cancer with lutetium-177-CC49.
Meredith, R. F., Partridge, E. E., Alvarez, R. D., Khazaeli, M. B., Plott, G., Russell, C. D., Wheeler, R. H., Liu, T., Grizzle, W. E., Schlom, J., et al. (1996) · PubMed · Cited by 107
Parry, J. J., Kelly, T. S., Andrews, R., & Rogers, B. E. (2007) · Bioconjugate Chemistry · doi:10.1021/bc0603788 · Cited by 106
Vilchis-Juárez, A., Ferro‐Flores, G., Santos‐Cuevas, C., Morales-Ávila, E., Ocampo‐García, B., Díaz, L., Luna‐Gutiérrez, M., Jiménez‐Mancilla, N., Pedraza-López, M., & Gómez‐Oliván, L. M. (2013) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2014.1721 · Cited by 103
Smith, C. J., Gali, H., Sieckman, G. L., Hayes, D. L., Owen, N. K., Mazuru, D. G., Volkert, W. A., & Hoffman, T. J. (2003) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(02)00391-8 · Cited by 99
Radiochemical separation of no-carrier-added as produced via the process
Lebedev, N. A., Novgorodov, A. F., Misiak, R., Brockmann, J., & Rösch, F. (2000) · Applied Radiation and Isotopes · doi:10.1016/s0969-8043(99)00284-5 · Cited by 98
Kaminsky, S. M., Levy, O., Salvador, C., Dai, G., & Carrasco, N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3789 · Cited by 96
Photodynamic Therapy of B16F10 Murine Melanoma with Lutetium Texaphyrin
Woodburn, K. W., Fan, Q., Kessel, D. H., Luo, Y., & Young, S. W. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00182.x · Cited by 96
Orlova, A., Jonsson, A., Rosik, D., Lundqvist, H., Lindborg, M., Abrahmsén, L., Ekblad, C., Frejd, F. Y., & Максимилианович, Т. В. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.110700 · Cited by 92
Vallabhajosula, S., Goldsmith, S. J., Hamacher, K. A., et al. (2005) · PubMed · Cited by 92
Treatment with 90Y- and 177Lu-DOTATOC in patients with metastatic neuroendocrine tumors
Frilling, A., Weber, F., Saner, F. H., Bockisch, A., Hofmann, M., Mueller‐Brand, J., & Broelsch, C. E. (2006) · Surgery · doi:10.1016/j.surg.2006.07.030 · Cited by 90
Intraperitoneal Radioimmunochemotherapy of Ovarian Cancer: A Phase I Study
Meredith, R. F., Alvarez, R. D., Partridge, E. E., Khazaeli, M. B., Lin, C.-Y., Macey, D. J., Austin, J. M., Kilgore, L. C., Grizzle, W. E., Schlom, J., et al. (2001) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/108497801753131381 · Cited by 90
Lipiodol solution of a lipophilic agent, 188Re-TDD, for the treatment of liver cancer
Jeong, J. M., Kim, Y. J., Lee, Y. S., Ko, J. I., Son, M., Lee, D. S., Chung, J.-K., Park, J. H., & Lee, M. C. (2001) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00208-0 · Cited by 89
Maddalena, M. E., Fox, J., Chen, J., Feng, W., Cagnolini, A., Linder, K. E., Tweedle, M. F., Nunn, A. D., & Lantry, L. E. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.064444 · Cited by 87
Advances in Nuclear Oncology: Microspheres for Internal Radionuclide Therapy of Liver Tumours
Nijsen, J. F. W., Schip, A. D. V. H., Hennink, W. E., Rook, D., van Rijk, P. P., & de Klerk, J. M. H. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867023371454 · Cited by 85
Debinski, W., Miner, R., Leland, P., Obiri, N. I., & Puri, R. K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.37.22428 · Cited by 83
Toyama, T., Aihara, Y., Iwasaki, T., Hasegawa, A., Suzuki, T., Nagai, R., Endo, K., Hoshizaki, H., Oshima, S., & Taniguchi, K. (1999) · PubMed · Cited by 83
68Ga-BPAMD: PET-imaging of bone metastases with a generator based positron emitter
Fellner, M., Biesalski, B., Bausbacher, N., Kubíček, V., Hermann, P., Rösch, F., & Thews, O. (2012) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2012.04.007 · Cited by 82
Dijkgraaf, I., Liu, S., Kruijtzer, J. A. W., et al. (2007) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2006.10.006 · Cited by 81
Shultz, M. D., Wilson, J. D., Fuller, C. E., Zhang, J., Dorn, H. C., & Fatouros, P. P. (2011) · Radiology · doi:10.1148/radiol.11102569 · Cited by 81
Samarium-153 and Lutetium-177 Chelation Properties of Selected Macrocyclic and Acyclic Ligands
Stimmel, J. B., & Kull, F. C. (1998) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(97)00151-0 · Cited by 79
Chakraborty, S., Das, T., Sarma, H. D., Venkatesh, M., & Banerjee, S. (2008) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2008.02.061 · Cited by 78
Self-citationKnapp, F. F., Mirzadeh, S., Beets, A. L., & Du, M. (2005) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-005-0083-4 · Cited by 77
Self-citation177 Lu-EDTMP: A Viable Bone Pain Palliative in Skeletal Metastasis
Chakraborty, S., Das, T., Banerjee, S., Balogh, L. P., Chaudhari, P. R., Sarma, H. D., Polyák, A., Máthé, D., Venkatesh, M., Jánoki, G. A., et al. (2007) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2007.374 · Cited by 73
Self-citationSchuchardt, C., Kulkarni, H., Prasad, V., Zachert, C., Müller, D., & Baum, R. P. (2012) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-27994-2_30 · Cited by 72
[177Lu]pertuzumab: experimental studies on targeting of HER-2 positive tumour cells
Persson, M., Максимилианович, Т. В., Andersson, K., Gedda, L., Sandström, M., & Carlsson, J. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1902-0 · Cited by 71
Mantey, S. A., Coy, D. H., Pradhan, T. K., Igarashi, H., Rizo, I. M., Shen, L., Hou, W., Hocart, S. J., & Jensen, R. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008737200 · Cited by 68
Chakravarty, R., Das, T., Dash, A. K., & Venkatesh, M. (2010) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2010.04.082 · Cited by 67
Tomblyn, M. B. (2012) · Cancer Control · doi:10.1177/107327481201900208 · Cited by 66
Chakraborty, S., Das, T., Sarma, H. D., Venkatesh, M., & Banerjee, S. (2008) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2008.03.003 · Cited by 65
Self-citationSainz-Esteban, A., Prasad, V., Schuchardt, C., Zachert, C., CARRIL, J. M., & Baum, R. P. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-2003-x · Cited by 62
Bisphosphonates as radionuclide carriers for imaging or systemic therapy
Palma, E., Correia, J. D. G., Campello, M. P. C., & Santos, I. (2011) · Molecular BioSystems · doi:10.1039/c1mb05242j · Cited by 61
Forrer, F., Chen, J., Fani, M., Powell, P., Lohri, A., Müller‐Brand, J., Moldenhauer, G., & Maëcke, H. R. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1120-2 · Cited by 60
Production of no-carrier-added 177Lu via the 176Yb(n, &;#947;)177Yb &;#8594; 177Lu process
Hashimoto, K., Matsuoka, H., & Uchida, S. (2003) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1023/a:1022557121351 · Cited by 60
Visualization of the thymus by substance P receptor scintigraphy in man
van Hagen, P. M., Breeman, W. A. P., Reubi, J. C., Postema, P. T., van den Anker-Lugtenburg, P. J., Kwekkeboom, D. J., Laissue, J. A., Waser, B., Lamberts, S. W. J., Visser, T. J., et al. (1996) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf01254476 · Cited by 56
Forrer, F., Oechslin-Oberholzer, C., Campana, B., Herrmann, R., Maëcke, H. R., Mueller‐Brand, J., & Lohri, A. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.115170 · Cited by 56
Hostetler, E. D., Jonson, S. D., Welch, M. J., et al. (1998) · The Journal of Organic Chemistry · doi:10.1021/jo981619a · Cited by 55
Long-term toxicity of [177Lu-DOTA0,Tyr3]octreotate in rats
Rolleman, E. J., Krenning, E. P., Bernard, B. F., et al. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0232-1 · Cited by 54
Production of 177Lu at the new research reactor FRM-II: Irradiation yield of 176Lu177Lu
Dvorakova, Z., Henkelmann, R., Lin, X., Türler, A., & Gerstenberg, H. (2007) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2007.08.013 · Cited by 51
Kelly, M. P., Lee, S. T., Lee, F.-T., et al. (2008) · The Prostate · doi:10.1002/pros.20856 · Cited by 50
Relative Biological Effectiveness of Alpha-Particle Emitters In Vivo at Low Doses
Howell, R. W., Azure, M. T., Narra, V. R., & Rao, D. V. (1994) · Radiation Research · doi:10.2307/3578710 · Cited by 49
Hermanne, Α., Takács, S., Goldberg, M. B., et al. (2006) · Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms · doi:10.1016/j.nimb.2006.03.008 · Cited by 47
Rasaneh, S., Rajabi, H., Babaei, M. H., & Daha, F. J. (2010) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2010.07.001 · Cited by 46
Auger electron emitters: Insights gained from in vitro experiments
Makrigiorgos, G. M., Adelstein, S. J., & Kassis, A. I. (1990) · Radiation and Environmental Biophysics · doi:10.1007/bf01210552 · Cited by 45
Practical aspects of peptide receptor radionuclide therapy with [177Lu][DOTA0, Tyr3]octreotate.
Bakker, W. H., Breeman, W. A., Kwekkeboom, D. J., et al. (2006) · PubMed · Cited by 44
Chen, J., Linder, K. E., Cagnolini, A., Metcalfe, E., Raju, N., Tweedle, M. F., & Swenson, R. E. (2007) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2007.11.007 · Cited by 43
Mohsin, H., Fitzsimmons, J., Shelton, T. D., et al. (2007) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2007.03.006 · Cited by 41
Concepts, Consequences, and Implications of Theranosis
DeNardo, G. L., & DeNardo, S. J. (2012) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2011.12.003 · Cited by 41
Luna‐Gutiérrez, M., Ferro‐Flores, G., Ocampo‐García, B., Jiménez‐Mancilla, N., Morales-Ávila, E., Rodriguez, L. M. D. L., & Isaac‐Olivé, K. (2012) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.2910 · Cited by 41
Miao, Y., Fisher, D. R., & Quinn, T. P. (2006) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2006.06.005 · Cited by 41
Integrin Targeted Delivery of Radiotherapeutics
Liu, Z., Wang, F., & Chen, X. S. (2011) · Theranostics · doi:10.7150/thno/v01p0201 · Cited by 40
Mohsin, H., Jia, F., Sivaguru, G., et al. (2006) · Bioconjugate Chemistry · doi:10.1021/bc0502356 · Cited by 39
Systemic radionuclide therapy in pain palliation
Liepe, K., Runge, R., & Kotzerke, J. (2005) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/104990910502200613 · Cited by 39
Lu, S. X., Takach, E. J., Solomon, M. S., Zhu, Q., Law, S., & Hsieh, F. Y. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20289 · Cited by 38
Therapeutic Radionuclides: Production, Physical Characteristics, and Applications
Srivastava, S. C., & Mausner, L. F. (2013) · Medical radiology · doi:10.1007/174_2012_782 · Cited by 36
Alternative chromatographic processes for no-carrier added 177Lu radioisotope separation
So, L. V., Morcos, N. A., Zaw, M., Pellegrini, P. A., & Greguric, I. D. (2008) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-007-7129-8 · Cited by 36
Manenti, S., Groppi, F., Gandini, A., et al. (2010) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2010.08.008 · Cited by 34
Bilewicz, A., Żuchowska, K., & Bartoś, B. (2009) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-008-7437-7 · Cited by 34
Pan, M., Gao, D., Feng, J., He, J., Seo, Y., Tedesco, J., Wolodzko, J. G., Hasegawa, B. H., & Franc, B. L. (2008) · Molecular Imaging and Biology · doi:10.1007/s11307-008-0185-9 · Cited by 32
Internal radiotherapy of painful bone metastases
Liepe, K., & Kotzerke, J. (2011) · Methods · doi:10.1016/j.ymeth.2011.07.001 · Cited by 31
Kneifel, S., Bernhardt, P., Uusijärvi, H., Good, S., Plaßwilm, L., Buitrago-Téllez, C. H., Müller‐Brand, J., Mäcke, H. R., & Merlo, A. U. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0351-8 · Cited by 28
Jiang, L., Miao, Z., Kimura, R. H., Liu, H., Cochran, J. R., Culter, C. S., Bao, A., Li, P., & Cheng, Z. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1684-x · Cited by 27
Swärd, C., Bernhardt, P., Johanson, V., Schmitt, A., Ahlman, H., Stridsberg, M., Forssell-Aronsson, E. B., Nilsson, O., & Kölby, L. (2008) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2007.0421 · Cited by 27
Activation of natural Hf and Ta in relation to the production of 177Lu
Medvedev, D., Mausner, L. F., Greene, G. A., & Hanson, A. L. (2008) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2008.02.090 · Cited by 27
Alternative chromatographic processes for no-carrier added 177Lu radioisotope separation
So, L. V., Morcos, N. A., Zaw, M., Pellegrini, P. A., Greguric, I. D., & Nevissi, A. E. (2008) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-007-7130-2 · Cited by 26
Reactor produced 177Lu of specific activity and purity suitable for medical applications
Mikołajczak, R., Parus, J. L., Pawlak, D., Zakrzewska, E., Michalak, W., & Sasinowska, I. (2003) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1023/a:1024784924154 · Cited by 25
Rogers, B. E., Roberson, P. L., Shen, S., Khazaeli, M. B., Carpenter, M., Yokoyama, S., Brechbiel, M. W., LoBuglio, A. F., & Buchsbaum, D. J. (2005) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2005.20.502 · Cited by 25
Bahrami‐Samani, A., Anvari, A., Jalilian, A. R., Shirvani‐Arani, S., Yousefnia, H., Aghamiri, M. R., & Ghannadi‐Maragheh, M. (2012) · PubMed Central · Cited by 23
Planning Combined Treatments of External Beam Radiation Therapy and Molecular Radiotherapy
Cremonesi, M., Ferrari, M. E., Botta, F., Guerriero, F., Garibaldi, C., Bodei, L., Cicco, C. D., Grana, C. M., Pedroli, G., & Orecchia, R. (2014) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2014.1607 · Cited by 21
Outcome of treating advanced neuroendocrine tumours with radiolabelled somatostatin analogues
Muros, M. A., Varsavsky, M., Rozas, P. I., Valdivia, J., Delgado, J. R., Forrer, F., Bodei, L., & Paganelli, G. (2009) · Clinical & Translational Oncology · doi:10.1007/s12094-009-0310-5 · Cited by 19
Kairemo, K., & Kangasmäki, A. (2012) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-27994-2_31 · Cited by 18
Shi, J., Liu, Z., Jia, B., Yu, Z., Zhao, H., & Wang, F. (2009) · Amino Acids · doi:10.1007/s00726-009-0382-0 · Cited by 17
Tracer level radiochemistry to clinical dose preparation of 177Lu-labeled cyclic RGD peptide dimer
Chakraborty, S., Sarma, H. D., Vimalnath, K. V., & Pillai, M. R. A. (2013) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2013.05.011 · Cited by 14
Self-citationDavì, M. V., Bodei, L., Ferdeghini, M., Falconi, M., Testoni, M., Paganelli, G., Oliani, C., Cascio, V. L., & Francia, G. (2008) · Endocrine Practice · doi:10.4158/ep.14.2.213 · Cited by 13
Selzer, E., & Kornek, G. V. (2013) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2013.841540 · Cited by 12
Production of GMP-compliant lutetium-177: radiochemical precursor for targeted cancer therapy
Chinol, M., Cutler, C. S., Papi, S., Ketring, A. R., Garaboldi, L., Paganelli, G., & Murray, L. (2010) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2010.04.035 · Cited by 6
The Coordination Number of Lu(III) in a Mixed System of Methanol and Water
Arisaka, M., Takuwa, N., & Suganuma, H. (2000) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1023/a:1006780404167 · Cited by 2
Cited by
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
Sartor, O., de Bono, J., Chi, K. N., Fizazi, K., Herrmann, K., Rahbar, K., Tagawa, S. T., Nordquist, L. T., Vaishampayan, N., El-Haddad, G., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2107322 · Cited by 2,864
Radiopharmaceutical therapy in cancer: clinical advances and challenges
Sgouros, G., Bodei, L., McDevitt, M. R., & Nedrow, J. R. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0073-9 · Cited by 963
Radioactive Main Group and Rare Earth Metals for Imaging and Therapy
Kostelnik, T. I., & Orvig, C. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00294 · Cited by 483
Chi, K. N., Armstrong, A. J., Krause, B. J., Herrmann, K., Rahbar, K., de Bono, J. S., Adra, N., Garje, R., Michalski, J. M., Kempel, M. M., et al. (2024) · European Urology · doi:10.1016/j.eururo.2023.12.004 · Cited by 37
Loharkar, S., & Basu, S. (2023) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2023.2211090 · Cited by 16
Metadata
- Authors
- Banerjee, S., Pillai, M. R. A., & Knapp, F. F. (.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-04-13
- Volume
- 115
- Issue
- 8
- Pages
- 2934-2974
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2089929576
- Cited by
- 321
- References
- 149
- FWCI
- 2.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.